Nowadays, we are facing a renaissance of mitochondria in cancer biology. However, our knowledge of the basic cell biology and on the timing and mechanisms that control the biosynthesis of mitochondrial constituents during progression through the cell cycle of mammalian cells remain largely unknown. Herein, we document the in vivo changes on mitochondrial morphology and dynamics that accompany cellular mitosis, and illustrate the following key points of the biogenesis of mitochondria during progression of liver cells through the cycle: (i) the replication of nuclear and mitochondrial genomes is synchronized during cellular proliferation, (ii) the accretion of OXPHOS proteins is asynchronously regulated during proliferation being the synthesis of b-F1-ATPase and Hsp60 carried out also at G2/M and, (iii) the biosynthesis of cardiolipin is achieved during the S phase, although full development of the mitochondrial membrane potential (DYm) is attained at G2/M. Furthermore, we demonstrate using reporter constructs that the mechanism regulating the accretion of b-F1-ATPase during cellular proliferation is controlled at the level of mRNA translation by the 39UTR of the transcript. The 39UTR-driven synthesis of the protein at G2/M is essential for conferring to the daughter cells the original phenotype of the parental cell. Our findings suggest that alterations on this process may promote deregulated b-F1-ATPase expression in human cancer.
INTRODUCTION
Cellular proliferation is an energy consuming activity that is stringently controlled by checkpoints of the cell cycle [1] . Transition from one phase of the cycle to the next is coordinated by the expression of specific cyclins and the sequential activation and inactivation of cyclin-dependent protein kinases [2] . Uncontrolled proliferation is one of the hallmarks of the cancer cell [3] that most often results from genetic alterations and/or the inactivation of master regulators of the cell cycle [4] . Cells that make the decision to divide must be therefore metabolically prepared to deal with the energetic demand imposed by proliferation. Alternatively, the cells can become reversibly arrested at the G1/S boundary (restriction point) of the cell cycle. In fact, compromising the cellular ATP levels by inhibition of mitochondrial oxidative phosphorylation [5, 6] or by limiting the availability of glucose [1] or by genetic alterations that compromise the bioenergetic activity of mitochondria [7] result in G1 arrest of the cells. The G1/S arrest is triggered by a metabolic stress checkpoint of the cycle that is controlled by the activation of AMP-activated protein kinase (AMPK) [1] which is a metabolic sensor of the energy charge in higher eukaryotic cells [8] . The activation of AMPK promotes the phosphorylation of p53 at Ser15 [1] , a modification that prevents its degradation and results in the cellular accumulation of p53 and cell-cycle arrest. Various studies have shown that entry of cells into the G1 phase of the cycle is associated with a burst of mitochondrial activity [5, 9] . However, it appears that progression through the cycle is supported by nonrespiratory modes of energy generation [10] [11] [12] . In fact, very recent findings in cells of mammals indicate that cyclin D1 which is involved in the phosphorylation and inactivation of the retinoblastoma protein, marking the entry of cells into the S phase of the cycle, inhibits mitochondrial function [13] and represses the activity of NRF-1 [14] , a nuclear factor that masters the transcriptional expression of nuclear-encoded mitochondrial genes [15] .
Mitochondria participate in a large number of essential cellular functions. Genetic or epigenetic alterations that impact on mitochondrial functions are thus involved in the development of human pathologies with quite different phenotypic presentations [16] , that include physiological ageing [17] . The provision of metabolic energy by oxidative phosphorylation (OXPHOS) is the best characterized function of mitochondria. In the process of oxidative phosphorylation, ATP is synthesized from ADP and Pi by the mitochondrial H + -ATP synthase [18] , a rotatory engine complex of the inner mitochondrial membrane that utilizes as driving force the proton electrochemical gradient generated by the respiratory chain [19] . The catalytic activity of the H + -ATP synthase is located in the b-subunit of the water-soluble F1 portion (b-F1-ATPase) of the complex which is encoded in the nuclear genome [20] . The regulation of the expression of b-F1-ATPase is exerted at the level of translation [21] [22] [23] [24] [25] . The b-F1-ATPase mRNA (b-mRNA) further provides an example of a mitochondrialocalized mRNA in both mammalian [26] [27] [28] [29] and lower eukaryotic cells [30, 31] whose efficient translation depends on the 39 non-translated region (39UTR) of the mRNA [24, 30, 32, 33] . Translation masking of b-mRNA occurred both in the fetal liver [24] and in hepatomas [25] , compromising the biogenesis of mitochondria during development and in oncogenesis [34, 35] .
The biogenesis of mitochondria is a complex cellular event requiring the concerted expression of two physically separated genomes [15, [35] [36] [37] . However, and despite the relevant role played by mitochondria in the onset and progression of human pathology, our knowledge of the timing of the biosynthesis of the different mitochondrial constituents and on the mechanisms that regulate their biosynthesis during cellular proliferation are scarce or remain largely unknown. Even less explored are the dynamics and changes in mitochondrial morphology during mitosis, a process that is likely to impact on the development of mitochondrial function and on the segregation of the organelles during progression through the cell cycle. Because of the renaissance of mitochondrial studies in cancer biology [38] [39] [40] [41] , in this work we have studied the timing of the biosynthesis of different mitochondrial constituents during progression through the cell cycle and the changes on mitochondrial morphology and dynamics that accompany cellular mitosis. Mechanistically, we document the relevance that the 39UTR (39 non-translated region) of b-mRNA has for the synthesis of the protein at G2/M and illustrate the role that a regulatory mRNA sequence has for the appropriate biogenesis of mitochondria in the daughter cells with the same bioenergetic phenotype than that of the parental cell. This discovery highlights a previously unappreciated relationship between the control of translation at G2/M and the biogenesis of mammalian mitochondria that is likely to influence the cancer field.
RESULTS

Biosynthesis of mitochondrial constituents during the cell cycle
Subconfluent cultures of liver C9 cells were synchronized by metabolic arrest at the beginning of the S phase (see Fig. S1 in Supporting Information). The arrest of the cell cycle promoted a significant increase in the proportion of cells in G0/G1 concurrent with a reduction of the proportion of cells in S and G2/M (Fig. S1 ). At various times (0-10 h) after release from the metabolic block cells were recovered and the relative cellular content of mtDNA (Fig. 1A ) and mitochondrial proteins (Fig. 1B) determined. It should be noted that at 4h after release from the arrest the percentage of cells in the different phases of the cycle were basically the same (Fig. S1 ) being the percentage of cells in G2/M 2-fold and 5-fold higher than that of non-arrested and arrested cells, respectively (Fig. S1 ). The relative cellular content of mitochondrial DNA (mtDNA), as determined by the ratio of the mitochondrial 12S rRNA gene to the nuclear b-F1-ATPase gene did not show significant deviations from the initially observed value (dotted line in Fig. 1A ), suggesting that synthesis of nuclear and mitochondrial DNA is coordinated during cell cycle progression. Contrary to this finding, we observed that the relative cellular content of the catalytic subunit of the mitochondrial H + -ATP synthase (b-F1-ATPase/tubulin ratio) and of the structural heat shock protein 60 (hsp60) (hsp60/ Figure 1 . Changes in mitochondrial constituents during the cell cycle. Synchronized C9 cells (A-C) were recovered at the indicated time intervals and the relative cellular content of mtDNA (A) and proteins (B-C) determined. No significant changes in the cellular abundance of the mitochondrial 12S gene are observed. However, the cellular content of b-F1-ATPase, Hsp60 and cyclin B1 showed a significant increase at 4 h after release from the metabolic arrest. Representative experiments are shown (A-C). * and **, P,0.05 and ,0.005 when compared with 0-2 h. D, The fluorescence intensity of the NAO probe was used to determine changes on mitochondrial mass during the cell cycle of non-synchronized C9 cells. The results shown are the means6SEM of three experiments. *, P,0.05 when compared with cells in G0/G1. doi:10.1371/journal.pone.0000107.g001
tubulin ratio) showed a significant increase at 4 h (Fig. 1B) . Analysis of the cellular expression level of cyclin B1 (cyclin B1/ tubulin ratio), that is known to peak at mitosis, also revealed a significant increase 4h after initiation of the cell cycle (Fig. 1C) , suggesting that mitosis is the cell-cycle phase where the preferential synthesis of these mitochondrial proteins is taking place.
To assess the build up of the inner mitochondrial membrane during progression through the cycle changes in the amount of cardiolipin were determined by flow cytometry using the fluorescent NAO probe (Fig. 1D) . The mean fluorescence intensity of NAO-stained cells increased significantly in S phase when compared to cells in G0/G1 (Fig. 1D) . No further significant changes were observed in NAO fluorescence in the cells at G2/M (Fig. 1D) , indicating that the biosynthesis of the phospholipid of the inner membrane is completed in S phase.
Asynchronous accretion of mitochondrial proteins during the cycle
The cellular content of various mitochondrial proteins was further analyzed by flow cytometry in non-synchronized C9 cells (see Fig.  S2 in Supplementary Information for controls of cytometry and representative experiments for each of the protein markers assayed). We observed that whereas the nuclear (COXIV) and mitochondrial (COXI) encoded subunits of respiratory complex IV (cytochrome c oxidase subunits IV and I, respectively) accumulated almost entirely during S phase ( Figs. 2A and S2 ), the accumulation of b-F1-ATPase and hsp60 occurred throughout the cycle with a significant increase at G2/M when compared to cells in S phase ( Figs. 2A and S2 ). The preferential build up of b-F1-ATPase and hsp60 at G2/M, and parallel accretion of these two proteins during the cycle, was further confirmed by western blotting of cells sorted according to their DNA content as revealed by the sharp increase in b-F1/COXIV ratio at G2/M (Fig. 2B ) and the lack of significant deviations in b-F1/hsp60 ratio (Fig. 2B) , respectively.
The preferential synthesis of b-F1-ATPase at G2/M occurs in the absence of changes in mRNA abundance
To explore the possibility that b-F1-ATPase mRNA abundance could be regulated during the cycle gearing the synthesis and accumulation of the protein we determined the relative cellular content of b-mRNA in synchronized C9 cells at various times after release from the metabolic block. The expression of bmRNA was determined (Fig. 2C ) in the same cultures where the protein expression was assessed (Fig. 1B) . No significant changes in the relative cellular content of b-mRNA (as assessed by any of the following ratios: b-mRNA/18S rRNA, b-mRNA/ ATPase 6-8 mRNA and b-mRNA/12S rRNA) was observed (Fig. 2C) . Furthermore, we also determined the relative expression of b-mRNA in cells sorted according to their DNA content and found the lack of significant changes in the normalized expression of b-mRNA in the different phases of the cycle (1.0060.10, 0.8360.12 and 1.2160.10 for cells in G0/ G1, S and G2/M, respectively). Overall, the results suggest that the accumulation of the protein during cellular proliferation (Figs. 1B, 2A and 2B) is mainly controlled at the level of translation although it cannot be excluded that mechanisms that control the subcellular localization of the mRNA [26] [27] [28] [29] 31] might as well contribute to the observed accretion of the protein during the cell cycle.
Functional differentiation of mitochondria during the cell cycle
To assess the stage of functional differentiation of mitochondria during the cell cycle, changes in the mitochondrial membrane potential (DYm) were determined by FACS analysis using the TMRM + probe. The mean fluorescence intensity of TMRMstained cells increased significantly in S phase when compared to cells in G0/G1 (Fig. 2D) . However, and contrary to the results observed with the NAO probe (Fig. 1D) , the mean fluorescence intensity of TMRM-stained cells further showed a significant increase at G2/M (Fig. 2D ), indicating that full development of DYm is attained only after G2/M-dependent events have been completed.
The presequence of b-F1-ATPase precursor targets gfp to the mitochondria
To test the possibility that changes in the translation efficiency of b-mRNA could trigger the accumulation of the protein during progression through the cycle we studied the expression of a gfp reporter derived from a construct that contained the 39UTR regulatory element of b-mRNA translation [24, 32] . However, and because of the cytotoxic effect of gfp when it is expressed in the cytoplasm [33] the development of stable cellular clones by this approach resulted unsuccessful. Therefore, we decided to target gfp to the mitochondria by inframe fusion at the N-terminal of gfp the presequence of the rat liver b-F1-ATPase precursor protein. This strategy allowed the generation of stable clones of mammalian cells that express gfp in their mitochondria (Fig. 3A) as assessed by confocal ( Fig. 3B ) and immunoelectron ( Fig. 3C ) microscopy. Interestingly, it was not possible to detect significant amounts of the pb-gfp chimeric protein in cellular extracts of the C9-pbGFP39b clone (see Fig. 3D , lane 1), suggesting a fast and efficient in vivo import of the chimeric protein in this cell line. However, when transfecting the same construct into BHK cells we detected the pb-gfp precursor (Fig. 3D, lane 2) . Moreover, treatment of these cells with carbonyl cyanide p-trifluoromethoxy-phenylhydrazone (FCCP), a drug that collapses DYm and prevents the import of precursor proteins into the organelle, revealed the rapid accumulation of pb-gfp in BHK cellular extracts (Fig. 3D, lanes 3 ). Upon removal of FCCP from the culture medium, the pb-gfp precursor was rapidly imported into mitochondria and processed to mature gfp (Fig. 3D, lane 4) . These results illustrate cell-type specific differences in the import pathway of proteins into mitochondria in cells of mammals.
Gfp derived from the C9-pbGFP39b clone is preferentially synthesized at G2/M Analysis of the relative cellular expression level of gfp in nonsynchronized C9-pbGFP39b cells, as assessed by the gfp/tubulin ratio, revealed a constant expression level of the protein as cells proliferate (data not shown). In contrast, the same analysis in synchronized C9-pbGFP39b cells revealed a significant and preferential accumulation of gfp at 4 h after release from the metabolic block (Fig. 4A) , indicating that the synthesis of gfp driven from the construct that contains the presequence and 39UTR of b-mRNA coincides with that of the endogenous b-F1-ATPase (Fig. 1B) and is preferential at the time of mitosis (Fig. 1C) . Determination of the relative cellular content of the chimeric gfpmRNA in synchronized C9-pbGFP39b cells revealed a constant expression level of this mRNA during the cycle (Fig. 4B) , suggesting that the accumulation of gfp at G2/M is controlled at the level of translation.
The 39UTR of b-mRNA controls the accumulation of the protein at G2/M In order to define which of the two b-mRNA elements (presequence and 39UTR) is responsible for the preferential synthesis of the protein at G2/M we generated additional stable clones of the C9 cell line in which the 39UTR of b-mRNA was replaced by the 39UTR of mitochondrial transcription factor A (Tfam). The 39UTR of Tfam lacks translation enhancing activity when compared to the activity of the 39UTRs of other OXPHOS transcripts [33] . Consistent with this, we observed that the expression of gfp in C9-pbGFP39Tfam cells was much less than that in C9-pbGFP39b cells (Fig. 4C) . However, the C9-pbGFP39Tfam clone also efficiently targeted gfp to mitochondria in C9 cells showing no cellular accumulation of the pb-gfp chimera (Fig. 4C , and data not shown).
To assess the role of the 39UTRs in the synthesis of gfp during the cycle we determined the relative changes in gfp fluorescence of the C9-pbGFP39b and C9-pbGFP39Tfam cells (Fig. 4D) . In both clones the mean fluorescence intensity of the cells increased as they progress through the cycle (Fig. 4D) . However, the relative increase in cellular fluorescence observed in C9-pbGFP39b cells exceeded by far that determined in C9-pbGFP39Tfam cells both in S phase and at G2/M (Fig. 4D) . In fact, C9-pbGFP39Tfam cells did not synthesize the amount of gfp that is required for appropriate cellular division into daughter cells with the same maternal gfp phenotype (Fig. 4D) . Therefore, the results support that the 39UTR of b-mRNA is the core controlling element required for the biosynthesis of b-F1-ATPase and for the appropriate biogenesis of mitochondria during cellular proliferation.
Dynamics of the mitochondrial network during mitosis
The mitochondrial network is a dynamic structure that is permanently subjected to remodeling by changes in the morphology and subcellular localization of the organelles [42] . Organelle changes are relevant for cellular metabolism [43] , the execution of apoptosis [6, 44] , Ca 2+ signaling [45] , viral infection [46] and impact on various human pathologies [47] . However, the timing of the morphological changes experienced by mitochondria during mitosis in cells of mammals is unknown. In this regard, the generation of mammalian cell lines with green mitochondria allowed us to visualize in vivo the morphology and dynamics of mitochondria during mitosis (see supporting video S1 and Fig. S3 ) as well as within the context of elements of the cytoskeleton (Fig. 5) .
The analysis of synchronized C9-pbGFP39b cells at 4h after release from the metabolic block confirmed that a large proportion of the cells (.40%) were undergoing mitosis (Fig. 5) . The morphology of mitochondria in cells in interphase is that of threads, or of a tubular network, that it is intertwined with the tubulin and actin cytoskeleton. Mitochondria in cells in interphase are preferentially clustered around the nucleus, although some mitochondria are also located in the cell periphery (Fig. 5) . By the time cells enter mitosis the mitochondrial tubular network is disorganized and fission of the thread-like organelles had occurred with some of the mitochondria already appearing as punctuate organelles (especially in metaphase) (Fig. 5) . During the early stages of mitosis mitochondria are excluded from the cellular space where the mitotic spindle is being assembled (prophase) as well as from the equator of the spindle where the chromosomes line up (metaphase) (Fig. 5) . During anaphase mitochondria still display a punctuate morphology appearing evenly distributed in the cell periphery (Fig. 5) . By the time of late-anaphase or early-telophase some punctuate mitochondria initiate the repopulation of the spindle equator after the segregation of the daughter chromosomes had occurred (Fig. 5) . In late-telophase, just before cytokinesis, mitochondria initiate their change in morphology also appearing as thread-like structures (Fig. 5) . Overall, the cellular distribution of mitochondria during mitosis appears not to be co-distributed with the majority of the tubulin and b-actin cytoskeleton (Fig. 5) . Of note is the enrichment of b-actin in the cell cortex (the red layer beneath the plasma membrane) during mitosis (Figs. 5g, 5h ) that governs the formation of filopodia (the thin red stiff protrusions on Fig. 5g ) responsible for promoting the dramatic changes in cell shape during mitosis (see phase contrast images on supporting video S1 and Fig. S3 ).
DISCUSSION
The timing of the biosynthesis of mtDNA in cells of mammals during progression through the cell-cycle is nowadays a matter of debate. In this regard, the replication of mtDNA has been described to proceed continuously during the cycle [48, 49] or to occur at a specific stage of the cycle (late S-G2/M) after most nDNA synthesis has been completed [50, 51] . The lack of significant changes on the cellular representation of mtDNA in liver cells during cellular proliferation suggests that mtDNA and nDNA synthesis is coordinated and supports a concerted transactivation of the replication of both genomes [52] . The synchronous replication of both genomes is not incompatible with localized [53] or delocalized synthesis of mtDNA [49] which might represent events of mtDNA turnover and/or repair of the nucleoid.
Consistent with the prominent role played by cardiolipin in translation of mitochondrial proteins and on the biogenesis of OXPHOS complexes ( [54] [55] [56] and references therein) we observed that synthesis of the mitochondrial encoded COXI protein is fully accounted in S phase concurrently with the synthesis of cardiolipin and of the nuclear-encoded counterpart subunit COXIV. However, we observed that a fully developed DYm is not attained until G2/M (Fig. 2D) [57] . The assembly and oligomerization of the H + -ATP synthase has been shown to play a critical role in the folding of the inner membrane into cristae morphology [58] [59] [60] . Moreover, in yeast cells the activity of the ATPase has been shown to be strictly required for the maintenance of mitochondrial integrity and mtDNA [61] . It is thus reasonable to suggest that the synthesis of b-F1-ATPase, and perhaps of other nuclear-encoded OXPHOS components whose synthesis is driven at G2/M, could rate-limit the development of a functional organelle during cellular proliferation.
The regulation of the expression of nuclear and mitochondrial genes during the cell cycle has been described at both the level of transcription [15, 62, 63] and by changes in the half-life of the mRNAs [15, [63] [64] [65] . However, the buildup of b-F1-ATPase during cellular proliferation occurs in the absence of changes in the cellular abundance of its mRNA consistent with the stringent translational control described for this transcript [21] [22] [23] [24] [25] . Moreover, the expression of a reporter driven from a chimeric mRNA containing the regulatory 39UTR of b-mRNA recapitulated the same pattern and mechanism of expression of the endogenous protein during cellular proliferation, providing the first indication that translation at G2/M is also required for the synthesis of an essential component of mitochondria, and supporting that cell-cycle regulated changes in the translational efficiency of some OXPHOS transcripts play a prominent role in the biogenesis of mitochondria.
It is well established that cap-dependent translation is inhibited at mitosis as a result of multiple events that lead to the disruption of the eIF4F complex [66] . At this stage of the cycle capindependent translation drives the synthesis of relevant cellular proteins from a set of internal ribosome entry site (IRES)-containing mRNAs [67] [68] [69] . Consistent with the synthesis of b-F1-ATPase at G2/M, the translation of b-mRNA has been shown to have a lesser dependence on eIF4E than other cellular mRNAs [32] . Moreover, the 39UTR of b-mRNA acts as a translation enhancing sequence [24, 33] that displays IRES-like activity in dicistronics constructs [32] . Therefore, an important conclusion resulting from this work is that the 39UTR-located IRES of b-mRNA is the target of cell cycle-dependent translational regulation.
The mammalian b-mRNA was the first nuclear-encoded transcript of the mitochondria shown to be localized and attached to the outer mitochondrial membrane [26] [27] [28] . Localization/ translation of the mRNA requires two cis-acting elements respectively located in the ORF and in the 39UTR of the mRNA [29] . The cis-acting element located on the ORF exerts a negative control on mRNA translation ( [24] and Santamaria and Cuezva, unpublished observation). For efficient translation of b-mRNA it is required the IRES-like translation enhancing activity of the 39UTR [24, 32] . Such translation enhancing activity of the 39UTR of b-mRNA has also been observed in the 39UTRs of other transcripts involved in the OXPHOS system of mammals [33] and yeast [31] cells. In fact, ablation of the 39UTR in the yeast b-F1-ATPase gene resulted in cells with respiratory deficiency [30] although such phenotype has been attributed to a defective import of b-F1-ATPase rather than to the activity of the 39UTR on translation. Consistent with this essential role of the 39UTR of the transcript in the synthesis of b-F1-ATPase our efforts to develop a mouse with a genetic deletion on the 39UTR of the b-F1-ATPase gene by homologous recombination (IngenKO, Australia) have resulted unsuccessful (data not shown).
The trans-acting factors of the 39UTR of b-mRNA that have been shown to control the translation of the mRNA during liver development [24] and in oncogenesis [25] have poly A binding activity [70] . Unfortunately, the molecular nature of these RNA binding proteins still remains elusive. However, we have recently observed that both a reduced environment and a low ATP/ADP ratio favor the binding of these proteins to its target [70] what results in translation masking of the mRNA [22, 24, 25] . A burst of mitochondrial respiration has been noted upon serum stimulation of quiescent mammalian cells [9] . However, progression through the cell cycle is stringently controlled by the regulation of the metabolic pathways involved in energy generation [10, 11, 71] . Essentially, the ''metabolic cycle'' during cellular proliferation alternates between a first oxidative phase that is characterized by the biosynthesis of many cellular components (G1 phase) and is supported by the energy derived from mitochondrial activity followed by a reductive phase were the replication of DNA and the biosynthesis of mitochondria (S/G2/M phases) is supported by non-respiratory modes of energy generation [10, 11, 71] . The operation of the metabolic cycle in cells of mammals have received recent support after the observation that cyclin D1 represses mitochondrial function in vivo [13, 14] . We therefore suggest that control of b-mRNA translation in the reductive phase that prevails at G2/M should have additional players that control the interactions of trans-acting factors of the 39UTR with its target to allow the translation of the mRNA in such unfavorable metabolic situation. Since the expression of b-F1-ATPase is down-regulated in most human cancers [38, 72] contributing to tumor progression [38, 39, 73] we believe that such regulators are responsible for promoting deregulated b-F1-ATPase expression in the cancer cell.
Finally, we presume that the rapid changes in mitochondrial morphology and dynamics that accompany mitosis might be of relevance for the appropriate segregation of the organelles and mtDNA into daughter cells during proliferation. We showed that fission of mitochondria is an early event of mitosis that might be triggered in response to the signaling cascades that accompany progression through the cell cycle. In fact, similar rapid fission events on the mitochondrial network are observed after treatment of the cells with an inhibitor of protein kinases [6] . Fission of the organelle is likely to be triggered by proteasomal degradation of mitofusins [74] . Functionally, fission of mitochondria assures a stochastic distribution of the organelles within the two daughter cells by a process that might be actively controlled and mediated by microtubules [75] . However, it has been reported that after mitochondrial fission 25-40% of the organelles lack mtDNA [76] . This situation could contribute to the asymmetric segregation of mtDNA into daughter cells explaining certain mtDNA depletion syndromes [47] . However, the fusion of mitochondria in late telophase, just before citokinesis, a process that is controlled by mitofusins and the development of DYm [77] , is likely to ameliorate the possible unequal distribution of mtDNA during cellular proliferation.
Overall, we have provided a comprehensive picture of the biogenesis of mammalian mitochondria during cellular proliferation and illustrated the relevance of translational control by the 39UTR of an OXPHOS mRNA for the appropriate biogenesis of the organelle during cell cycle progression. We hope that these findings will contribute to the understanding of certain human pathologies that impinge on organelle malfunction as a result of deregulated cellular proliferation.
MATERIALS AND METHODS
Cell cultures
Rat liver clone 9 (C9) and BHK (Baby Hamster Kidney) cells were grown at 37uC in DMEM with 10% fetal calf serum (FCS) [6] . Liver C9 cells were arrested at the beginning of S phase by a double thymidine block. In brief, subconfluent cultures were treated with 2 mM thymidine for 10 h. Afterwards, the cells were washed twice with DMEM and then grown for 6 hours in drug-free medium supplemented with 24 mM 29-deoxycytidine. Cells were arrested for a second time with 2 mM thymidine for 10 h and after grown in DMEM containing 24 mM 29-deoxycytidine.
DNA constructs and cellular cloning
The pJMI-b-F1 plasmid [24] , that contains the full-length rat liver b-F1-ATPase cDNA, was digested with Ban I for obtaining the fragment encoding the mitochondrial targeting sequence of b-F1-ATPase. The resulting cDNA fragment was cloned in the Eco 47 III site of plasmids CDL-GFP-b-39UTR and CDL-GFP-Tfam-39UTR [33] , that express chimaeric RNAs of GFP with the 39-UTRs of b-F1-ATPase and Tfam mRNAs, respectively. The sequence of the resulting plasmids pb-GFP-b-39UTR and pb-GFP-Tfam-39UTR, both expressing the same fusion protein between the mitochondrial targeting sequence of b-F1-ATPase and GFP (pb-gfp), was verified by automated DNA sequencing. Cells were transfected at 60-80% confluence using 1 ml of FUGENE 6 (Boehringer Mannheim, Germany) and 0.5 mg of DNA/1610 5 cells in 1 ml of culture medium [33] . Positive cells expressing gfp in their mitochondria were selected by incubation with 40 mg/ml of geneticin (G-418) (GIBCO) and cloning cylinders (868 mm).
Nucleic acids hybridizations
DNA and RNA were extracted from C9 cells and processed for hybridization of nucleic acids onto nylon membranes (GeneScreen) [33] . Membranes were incubated with [ 32 P]dCTP-labeled DNA probes [25] , exposed to X-ray films and analyzed by densitometry. Cytoplasmic RNA of sorted cells was extracted with RNeasy mini kit (Qiagen) following the manufacturer instructions. RNA quality was assessed previously to retro-transcription (RT) with High-Capacity cDNA Archive Kit (Applied Biosystems). qPCR was carried out on three different RT reactions. Oligonucleotides used for qPCR amplification were: 59-gcaattattccccatgaacg-39 and 59-gggacttaatcaacgcaagc-39 for 18S rRNA; 59-ggtatggaatcctgtggcatccatgaaa-39 and 59-gtgctaaaacgcagctcagtaacagtcc-39 for b-Actin mRNA and 59-aaagctggtgcccctgaag-39 and 59-ggagatggtcatagtcacctgct-39 for b-F1-ATPase mRNA. For qPCR, 5 ng of cDNA (template) and 0.5 mM of each primer together with Power Sybr Green PCR Master Mix (Applied Biosystems) were used following the protocol: 109695uC followed by 20-40 cycles of denaturation (150695uC) and annealingelongation (19660uC) with fluorescence acquisition at 60uC. A melting curve (150695uC, 150660uC and 150695uC) with fluorescence acquisition at 60u to 95uC was included in each qPCR. The amplification efficiency of each primer was empirically determined and applied to the relative quantification of the data using qbase software (http://medgen.ugent.be/qbase/).
Western-blots
Cells were recovered from the plates by trypsin treatment, washed twice with PBS and boiled in loading buffer. Cellular proteins were fractionated on SDS-12% PAGE and then transferred onto PVDF membranes for immunoblot analysis [25] . The primary monoclonal antibodies used were: anti-GFP (Clontech, 1:1000), anti-a-tubulin (Sigma, 1:1000), anti-hsp60 (Stressgene SPA807, 1:3000), anti-COXIV (Molecular Probes, 1:100) and anti-cyclin B1 (Santa Cruz Biotechnology, 1:100). The primary polyclonal antibody used was anti-b-F1-ATPase (1:30000) [38] . Peroxidase-conjugated anti-mouse or anti-rabbit IgGs (Nordic Immunology, 1:3000) were used as secondary antibodies. The blots were developed using the ECLH reagent (Amersham Pharmacia Biotech, Little Chalfont, U.K.).
Mitochondrial membrane potential (DYm) and mitochondrial mass
The fluorescent TMRM + and NAO probes (Molecular Probes, Eugene, Oregon) were used to analyze DYm and mitochondrial mass by flow cytometry, respectively [6] . The cellular fluorescence intensity was measured using a FACScan flow cytometer (BectonDickinson, San José, CA.). For each analysis 10,000 events were recorded.
Flow Cytometry Analysis
For the determination of the cellular content of mitochondrial proteins in the different phases of the cell cycle, ,1610
6 C9 cells were washed in ice-cold staining buffer (1% BSA, 1% FCS and 0.01% sodium azide in PBS) and further incubated with primary monoclonal antibodies against b-F1-ATPase (Molecular Probes, 0.02 mg/ml), Hsp60 (Stressgene, 0.01 mg/ml), COXI and COXIV (Molecular Probes, both at 0.04 mg/ml) in staining buffer supplemented with 0.3% saponin. The cells were then washed in ice-cold PBS-saponin buffer and incubated in the dark for 20 min with goat anti-mouse IgG conjugated to Alexa 488. Finally, the cells were resuspended in PBS-staining buffer containing 5 mg/ml of propidium iodide (Sigma) and 100 mg/ml RNase A and further incubated for 20 min at 37uC.
For the determination of the cellular content of the expressed gfp in C9-pbGFP39b and C9-pbGFP39Tfam cells, ,1610
6 cells were fixed with 0.25% paraformaldehyde in PBS for 5 min. After, the cells were resuspended in 70% ice-cold ethanol, collected by centrifugation and finally incubated for 30 min at 37uC in PBS containing 100 mg/ml of RNase A and 20 mg/ml of propidium iodide. The mean fluorescence intensity of the cells was determined after excitation at a wavelength of 488nm on a FACScan. For computer analysis only the signals from single cells were considered (10,000 cells/assay). Data analysis was carried out using Flow Jo 6.4.1 for Mac.
For the separation of the cells in G0/G1, S and G2/M phases of the cycle, cells were stained for 10 minutes with 5 mg/ml of Hoescht 33342 added to the culture media. Cells (,5610 6 cells/ml) were resuspended in PBS containing 5 mM EDTA, 25 mM HEPES pH 7.0 and the cellular aggregates removed by filtration through 70 mm pore filters. Cells were sorted in a FACSCVantage SE (BD Biosciences, Erembodegen, Belgium) according to their DNA content and collected in 0.5 ml of FCS. The purity of each fraction was assessed in an aliquot of propidium iodide stained cells.
Immunofluorescence/confocal microscopy
Fluorescence and indirect immunofluorescence microscopy was performed on mitochondria-tagged gfp C9 cells as recently described in detail [6] . The primary antibodies used were mouse monoclonal anti-a-tubulin and anti-b-actin (both from Sigma, 1:200). The primary polyclonal antibody used was anti-b-F1-ATPase (1:1000) [38] . After three PBS rinses, the cells were incubated for 1 h in the dark with goat anti-mouse or goat antirabbit IgGs conjugated to Alexa 594 (Molecular Probes) at 1:1000 dilution. The nuclei were stained with ToPro3 (Molecular Probes). Cellular fluorescence was analyzed by confocal microscopy using a Biorad Radiance 2000 Zeiss Axiovert S100TV using the following excitation/emission wave lengths: green (498/516 nm), red (590/ 617 nm) and blue (642/661 nm). The fluorescence emission of gfp was also analyzed in a Leica DMIRB fluorescence microscope equipped with a gfp excitation filter (Leica, BP 470/40).
Immunocytochemical localization of gfp by electron microscopy
Cells were fixed in freshly prepared 4% paraformaldehyde in 0.1 M Sörensen phosphate buffer, pH 7.2, for 2 h at 4uC. The free-aldehyde groups were quenched with 50 mM ammonium chloride in PBS for 60 min at 4uC. Samples were dehydrated in acetone and finally processed for embedding in Lowicryl K4M (Polysciences Europe, Eppelheim, Germany) [27] . Ultrathin sections were collected in collodion/carbon-coated nickel grids. Grids were incubated for 5 min with PBS containing 1% BSA and then incubated with anti-gfp (1:100). After three washes with PBS, grids were incubated for 45 min with goat anti-rabbit IgGs conjugated with 10 nm colloidal gold (British BioCell, Cardiff, UK). The grids were washed twice in PBS and distilled water, and air-dried. Counterstaining was performed with 2% aqueous uranyl acetate (6 min) and Reynolds lead citrate (45 s). Observation was performed in a Jeol 1010 electron microscope under 80 kV accelerating voltage.
Online supplementary material
For live imaging presented in the supplementary video, mitochondria-tagged gfp C9 cells were grown on glass plates and live images were taken in a Cell Observer Zeiss equipment using a Zeiss Axiovert 200 inverted microscope equipped with a Coolsnap FX CCD camera (Roper Scientific). Phase contrast and fluorescence images were taken every 3 min for 20 frames (1 h) with a 406 objective and a gfp filter. The Metamorph 6.1r6 (Universal Imaging) program was used for image processing. Figure S1 Analysis of the level of synchrony in cell cultures. C9 cells were treated as described to induce the arrest of the cell cycle at the G0/G1-S transition. After the release from the arrest, cells were grown and analyzed by flow cytometry at different timepoints after DNA staining with propidium iodide. The panels illustrate the cell cycle profiles of representative experiments for control, arrested and 2-h and 4-h after the release from the arrest. 
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